Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Future acne treatments should aggressively target inflammation to prevent scarring.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Antibody treatments show promise for hair loss but need more research.

Dupilumab may cause hair loss in some patients with severe atopic dermatitis.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Celiac disease requires more than just a gluten-free diet for effective management.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Pregnancy right after giving birth in mice lacking IL-10 causes milk that leads to liver issues and hair loss in their babies.

S100A7 and IL-17 may contribute to inflammation in lichen planopilaris.

Punica granatum leaf extract may help treat skin fibrosis by reducing inflammation and oxidative stress.

Alopecia areata patients have higher IgE and IL-13 levels, suggesting immune involvement.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Higher IL-17A levels indicate more severe alopecia areata.

3-Deoxysappanchalcone helps human hair cells grow and stimulates hair growth in mice by affecting certain cell signaling pathways.